Clinical Trial Update: S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer [NA]

View source ↗

Summary

SWOG's S1011 trial comparing standard versus extended pelvic lymphadenectomy in invasive bladder cancer completed. Results were posted on 2024-11-29.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer | NA | Status: COMPLETED | Results posted: 2024-11-29